Interventional technology firm Medtronic has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its PoleStar N30 neuro-oncology surgical MRI system.
The intraoperative MRI scanner is designed to help optimize tumor resection procedures, according to the Minneapolis-based firm.
Related Reading
Medtronic gets FDA nod for stent system, April 21, 2010
Medtronic brings SureScan to Europe, March 17, 2010
Medtronic pledges $1M for Haiti relief, January 22, 2010
Medtronic hires new VP, December 3, 2009
Medtronic launches 3D service with Vital, November 19, 2009
Copyright © 2010 AuntMinnie.com